Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Title
NOT-HD-03-011 January 1, 2027 COLLABORATIVE PEDIATRIC CRITICAL CARE RESEARCH NETWORK
NOT-HD-11-026 January 1, 2027 Close-out of the Extramural Associates Research Development Award (EARDA) Program and Clarification of the Eligibility of Current and Previous EARDA Grantees for Participation in the Biomedical/Biobehavioral Research Development (BRAD) Program (G11)
RFA-OD-22-010 July 2, 2024 R61/R33 Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
PAR-23-159 October 18, 2024 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-22-101 October 18, 2024 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-23-160 October 18, 2024 R03 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
PAR-22-100 October 18, 2024 R03 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
PAR-23-199 May 26, 2025 U24 ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
NOT-HD-12-021 January 1, 2027 Clarification/Update of Areas of Research Focus for PAR-12-102, Academic-Community Partnership Conference Series (R13)
NOT-HD-12-022 January 1, 2027 Clarification/Update of Areas of Research Focus for PAR-12-093, Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE) in Maternal and Child Health (R15)
NOT-RM-11-012 January 1, 2027 Clarification, Institutional Clinical and Translational Science Award (U54), RFA-RM-10-020
NOT-MH-05-024 January 1, 2027 Clarification to RFA-MH-06-007: Development of Recombinase-Expressing (“Driver”) Mouse Lines for Studying the Nervous System (U01)
NOT-HD-13-004 January 1, 2027 Clarification of the Scope of Research Projects to be Supported by PAR-13-206 Biophysical and Biomechanical Aspects of Embryonic Development (R21)
NOT-HD-13-011 January 1, 2027 Clarification of the Scope for PAR-13-095 "Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) into Developing or Damaged Tissues (R21)"
NOT-HD-13-010 January 1, 2027 Clarification of the Scope for PAR-13-094 "Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) into Developing or Damaged Tissues (R01)"
NOT-HD-20-029 January 1, 2027 Clarification of the Role of the Intramural Investigator in PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
NOT-CA-09-032 January 1, 2027 Clarification of Specific Research Objective in PAR-09-224, Improving Diet and Physical Activity Assessment (R01)
NOT-HD-17-017 January 1, 2027 Clarification of RFA-HD-18-009 "Global Network for Women's and Children's Health Research (UG1)"
NOT-HD-06-011 January 1, 2027 Clarification of Review Criteria for RFA-HD-06-018, International Extramural Associates Research Development Award (IEARDA) (G11)
NOT-OD-08-016 January 1, 2027 Clarification of Requirements for the NIH Partners in Research Program (R03) RFA-OD-07-001
top of pageBACK TO TOP